Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Literature
1.
Strady C, Penalba C, Baumard S, Brodard V, Wynckel A, Auvray C et al (2009) Nephropathia epidemica and leptospirosis in Champagne-Ardenne, France: comparison of clinical, biological and epidemiological profiles. Eur J Clin Microbiol Infect Dis 28:825–829CrossRefPubMed
2.
Clement J, van der Groen G, Lameire N, Colson P, Van Ranst M (2004) Acute non-cardiogenic pulmonary edema in a 2003 French Puumala-virus case: cautions and corrections. Clin Nephrol 61:364–365PubMed
3.
Rollin PE, Bowen MD, Kariwa H, Saluzzo JF, Guerard S, Flechaire A et al (1995) Short report: isolation and partial characterization of a Puumala virus from a human case of nephropathia epidemica in France. Am J Trop Med Hyg 52:577–578PubMed
4.
Saluzzo J-F, Coudrier D, Sureau P (1990) Novel data concerning serological and virological diagnosis of HFRS in France. Bull Epidémiol Hebdom 35:149 (in French)
5.
Wolf C, Michel N, Ottavioli JN, Dion JJ, Favriel JM (1990) Epidemiology of hemorrhagic fever with renal syndrome in the Ardennes region. Presse Méd 19:1369 (in French)PubMed
6.
van der Groen G, Beelaert G, Hoofd G, Leirs H, Verhagen R, Yamanishi H et al (1987) Partial characterization of a Hantavirus isolated from a Clethrionomys glareolus captured in Belgium. Acta Virol 31:180–184PubMed
7.
van der Groen G, Piot P, Desmyter J, Colaert J, Muylle L, Tkachenko EA et al (1983) Seroepidemiology of Hantaan-related virus infections in Belgian populations. Lancet 2:1493–1494
8.
Rollin PE, Bowen MD, Kariwa H, Saluzzo JF, Guerard S, Flechaire A et al (1999) Short report: isolation and partial characterization of a Puumala virus from a human case of nephropathia epidemica in France. Erratum in: Am J Trop Med Hyg 61:177
9.
Bowen MD, Kariwa H, Rollin PE, Peters CJ, Nichol ST (2001) Genetic characterization of a human isolate of Puumala hantavirus from France. Erratum in: Virus Res 79:201
10.
Billecocq A, Coudrier D, Boué F, Combes B, Zeller H, Artois M et al (2003) Expression of the nucleoprotein of the Puumala virus from the recombinant Semliki Forest virus replicon: characterization and use as a potential diagnostic tool. Clin Diagn Lab Immunol 10:658–663PubMed
Metadata
Title
Puumala virus reference strain for hantavirus serodiagnosis in France
Authors
J. Clement
G. van der Groen
P. Maes
M. Van Ranst
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0829-y

Other articles of this Issue 1/2010

European Journal of Clinical Microbiology & Infectious Diseases 1/2010 Go to the issue

Response

Response to the letter to the Editor (Dr Jan Clement et al)

Article

A mathematical model to study the effect of hepatitis B virus vaccine and antivirus treatment among the Canadian Inuit population

Article

Interaction of the heptavalent pneumococcal conjugate vaccine and the use of individual antibiotics among children on nasopharyngeal colonization with erythromycin-resistant Streptococcus pneumoniae

Article

Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective review

Article

Hantavirus nephropathy as a pseudo-import pathology from Ecuador

Article

Molecular characteristics of pharyngeal and invasive emm3 Streptococcus pyogenes strains from Norway, 1988–2003
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits